Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2114-2128
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2114
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2114
Figure 6 Propofol attenuates gastric cancer progression by miR-125b-5p/STAT3 axis.
A–C: SGC7901 and BGC823 cells were treated propofol, or cotreated with propofol and miR-125b-5p inhibitor or pcDNA.1-STAT3. A and B: MTT assays analyzed the cell viability; C: Flow cytometry measured apoptosis. n = 3, mean ± SD, bP < 0.01.
- Citation: Liu YP, Qiu ZZ, Li XH, Li EY. Propofol induces ferroptosis and inhibits malignant phenotypes of gastric cancer cells by regulating miR-125b-5p/STAT3 axis. World J Gastrointest Oncol 2021; 13(12): 2114-2128
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2114.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2114